GYRE THERAPEUTICS, INC. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFC14A
DEFM14A
DFAN14A
EFFECT
FWP
PRE 14A
PREC14A
PREM14A
PRER14A
PRRN14A
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0001950047-24-002421 | Mar 15, 2024 | — |
| 8-K | 8-K | 0001140361-24-008051 | Feb 14, 2024 | Feb 8, 2024 |
| SC 13G/A | — | 0000935836-24-000173 | Feb 14, 2024 | — |
| SC 13D/A | SC 13D/A | 0001140361-24-003688 | Jan 24, 2024 | — |
| 8-K/A | 8-K/A | 0001140361-24-002903 | Jan 19, 2024 | Dec 11, 2023 |
| 8-K/A | 8-K/A | 0001140361-24-002118 | Jan 12, 2024 | Oct 30, 2023 |
| 8-K | 8-K | 0001140361-23-057889 | Dec 15, 2023 | Dec 11, 2023 |
| 8-K | 8-K | 0001140361-23-056503 | Dec 6, 2023 | — |
| RW | RW | 0001140361-23-055209 | Nov 29, 2023 | — |
| SC 13D/A | SC 13D/A | 0001140361-23-054720 | Nov 27, 2023 | — |
| 4 | — | 0001140361-23-054522 | Nov 22, 2023 | Oct 30, 2023 |
| 4 | — | 0001140361-23-054516 | Nov 22, 2023 | Nov 20, 2023 |
| 4 | — | 0001140361-23-054518 | Nov 22, 2023 | Nov 20, 2023 |
| 4 | — | 0001140361-23-054520 | Nov 22, 2023 | Nov 20, 2023 |
| 3/A | — | 0001140361-23-054506 | Nov 22, 2023 | Oct 30, 2023 |
| 4 | — | 0001140361-23-054511 | Nov 22, 2023 | Nov 20, 2023 |
| 4 | — | 0001140361-23-054514 | Nov 22, 2023 | Oct 30, 2023 |
| 8-K | 8-K | 0001140361-23-053086 | Nov 14, 2023 | — |
| S-3 | S-3 | 0001140361-23-052634 | Nov 13, 2023 | — |
| 8-K | 8-K | 0001140361-23-052715 | Nov 13, 2023 | — |
| D | — | 0001140361-23-052961 | Nov 13, 2023 | — |
| 8-K | FORM 8-K | 0001140361-23-051485 | Nov 6, 2023 | — |
| 8-K | FORM 8-K | 0001140361-23-051195 | Nov 2, 2023 | Oct 30, 2023 |
| 3 | — | 0001140361-23-050608 | Nov 1, 2023 | Oct 30, 2023 |
| 3 | — | 0001140361-23-050611 | Nov 1, 2023 | Oct 30, 2023 |
| 3 | — | 0001140361-23-050607 | Nov 1, 2023 | Oct 30, 2023 |
| 4 | — | 0001140361-23-050619 | Nov 1, 2023 | Oct 31, 2023 |
| 3 | — | 0001140361-23-050609 | Nov 1, 2023 | Oct 30, 2023 |
| 3 | — | 0001140361-23-050610 | Nov 1, 2023 | Oct 30, 2023 |
| 4 | — | 0001140361-23-050620 | Nov 1, 2023 | Oct 31, 2023 |
| 3 | — | 0001140361-23-050612 | Nov 1, 2023 | Oct 30, 2023 |
| 4 | — | 0001140361-23-050614 | Nov 1, 2023 | Oct 31, 2023 |
| 4 | — | 0001140361-23-050615 | Nov 1, 2023 | Oct 31, 2023 |
| 4 | — | 0001140361-23-050616 | Nov 1, 2023 | Oct 31, 2023 |
| 4 | — | 0001140361-23-050617 | Nov 1, 2023 | Oct 31, 2023 |
| 3 | — | 0001140361-23-050613 | Nov 1, 2023 | Oct 30, 2023 |
| 4 | — | 0001140361-23-050618 | Nov 1, 2023 | Oct 31, 2023 |
| SC 13D/A | SC 13D/A | 0001140361-23-050866 | Nov 1, 2023 | — |
| 424B3 | 424B3 | 0001140361-23-050892 | Nov 1, 2023 | — |
| 4 | — | 0001140361-23-050569 | Oct 31, 2023 | Oct 27, 2023 |
| S-8 | FORM S-8 | 0001140361-23-050314 | Oct 31, 2023 | — |
| SC 13D/A | SC 13D/A | 0001140361-23-050328 | Oct 31, 2023 | — |
| 8-K | FORM 8-K | 0001140361-23-050292 | Oct 30, 2023 | Oct 27, 2023 |
| 4 | — | 0001140361-23-050019 | Oct 27, 2023 | — |
| 424B3 | FORM 424B3 | 0001140361-23-049997 | Oct 27, 2023 | — |
| 8-K | 8-K | 0001140361-23-050007 | Oct 27, 2023 | Oct 26, 2023 |
| 3 | — | 0001140361-23-050021 | Oct 27, 2023 | — |
| EFFECT | — | 9999999995-23-003116 | Oct 27, 2023 | — |
| 10-Q | 10-Q | 0000950170-23-055695 | Oct 26, 2023 | Sep 30, 2023 |
| CORRESP | — | 0001140361-23-049323 | Oct 24, 2023 | — |